Inari Medical (NARI) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

CEO pay ratio

CEO Salary

Median Employee Salary

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Climate Environment Environmental Intensity Materials Nature Offset Package Packaging Pandemic Raw Materials Water Access African American Asian Benefits Black California Consumer Privacy Act Charitable Collective Bargaining Community Culture Customer Cyber Cybersecurity Data Privacy Data Security Death Disability Diversity Employee Engagement Ethnicity Gender General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Hispanic Human Capital Incident Injuries Injury LGBTQ Perquisites Privacy Product Safety Recall Recruit Reimbursement Retention Retirement Safety Satisfaction Sexual Harassment Skill Skilled Skills Social Societal Society Stakeholder Supplier Supply Chain Talent Training Union Workers Workforce Anti-corruption Assessment Assurance Audit Bonus Bribery Chronic Classified Classified Board Commitment Conflict of Interest Corporate Governance Corporate Purpose Corruption Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Lead Independent Director Leadership Litigation Long-term Majority Mission Oversee Oversight Perquisite Pledging Procurement Purpose Quality Standard R&D Reputation Reputational Research and Development Responsibility Responsible Self-evaluation Special Meeting Stockholder Engagement Strategy Sustainability Sustainable Targets Tax Transparency Transparent

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

The annual meeting of shareholders of Inari Medical, Inc. (the “Company”) was held on May 26, 2022. The final voting results for each proposal are set forth below.

1.Each of the following Class II director nominees was elected to serve on the Company’s board of directors for a three-year term expiring at the Company’s 2025 annual meeting of shareholders, by the following vote:

Name of Nominee	Votes For	Votes Withheld	Broker Non-Votes

Dona G. Mead, Jr.	35,959,814	5,509,355	6,877,298
Kirk Nielsen	30,381,282	11,083,496	6,881,689
Catherine Szyman	32,369,734	9,095,044	6,881,689

2.The shareholders ratified the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. The votes regarding this proposal were as follows:

	Votes For		Votes Against		Abstentions		Broker Non-Votes

	48,308,481		12,315		25,671		0

3.The shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in our proxy statement. The votes regarding this proposal were as follows:

	Votes For		Votes Against		Abstentions		Broker Non-Votes

	36,070,016		5,283,156		115,997		6,877,298

4.The shareholders approved the advisory vote on the frequency of future advisory votes on executive compensation to be held every one year. The votes regarding this proposal were as follows:

	Votes For 1 yr.		Votes For 2 yr.		Votes For 3 yr.		Abstentions		Broker Non-Votes

	38,537,361		74,627		2,810,605		46,575		6,877,298

No other matters were submitted for shareholder action.